health_en

Gan & Lee receives EMA orphan drug designation for Phase I drug candidate GLR2007 for the treatment of glioma

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), a global biopharmaceutical company, today announced that the European Medicine Agency (EMA) Committee for Orphan Medicinal Products granted orphan drug designation for the investigational compound GLR2007, for the treatment of glioma. Glioma is a broad term describing neuroepithelial tumors […]

thaipr.net

8 เม.ย. 64

Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover

– Crossover allows participants to continue in trials and remain blinded– Ensures that all trial participants receive active vaccine– South Africa and UK crossover arms initiated; US/Mexico PREVENT-19 crossover planned Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the initiation of crossover arms in two ongoing clinical […]

thaipr.net

7 เม.ย. 64

GemVax’s highly promising Phase II Alzheimer’s disease clinical trial results targeting telomerase published in prestigious Alzheimer’s Research & Therapy’ journal

GemVax & KAEL Co., Ltd. (Korea: 082270) (“GemVax”) has announced that a paper on GV1001, a novel Alzheimer’s treatment based on telomerase modification, was published on March 26th in the SCI-grade international journal ‘Alzheimer’s Research & Therapy’. The paper is titled ‘Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer’s already receiving donepezil: a phase 2…

thaipr.net

1 เม.ย. 64

Johnson & Johnson Announces Advance Purchase Agreement with the African Vaccine Acquisition Trust for the Company’s COVID-19 Vaccine Candidate

Up to 400 million doses of the Company’s single-shot vaccine candidate will be made available to African Union member states Availability of the vaccine is subject to national regulatory approvals Data have demonstrated vaccine candidate protects against COVID-19 related hospitalization and death in broad geographic regions, including those with variants of significant concern Janssen Pharmaceutica […]

thaipr.net

29 มี.ค. 64

Saxenda® recommended for approval by European Medicines Agency committee for the treatment of obesity in adolescents aged 12–17 years

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda® is expanded for the treatment of obesity in adolescents aged 12–17 years.1 Over the last 20 years, the global prevalence of obesity in children and adolescents has doubled from […]

thaipr.net

29 มี.ค. 64

Airway Therapeutics Announces FDA Acceptance of IND for AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)

Initiating Phase 1b randomized clinical trial with initial results expected in late 2021 Potential for novel, preventive AT-100 to reduce incidence and severity of serious respiratory disease BPD, improving outcomes and survival in very preterm infants Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and […]

thaipr.net

26 มี.ค. 64
1 … 114 115 116 117 118 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.